-
Stockler, M, Zannino, D, Wilson, K, Gebski, V, Abdi, EA, Strickland, A, Lowenthal, RM, Simes, RJ, Price, TJ, Tebbutt, NC.
Patient-rated outcomes (PRO) in a randomized trial of first-line chemotherapy with capecitabine (C), bevacizumab (B), and mitomycin-C (M) for metastatic colorectal cancer: The AGITG MAX trial..
Journal of Clinical Oncology
28(15_suppl)
:
e14036 -e14036
2010
view publication
-
Schofield, P, Stockler, M, Zannino, D, Wong, N, Ransom, D, Moylan, E, Simes, RJ, Price, TJ, Tebbutt, NC, Jefford, M.
Hope, optimism, and survival in a randomized trial of first-line chemotherapy for patients with metastatic colorectal cancer..
Journal of Clinical Oncology
28(15_suppl)
:
9039 -9039
2010
view publication
-
Burgess, DC, Hunt, D, Li, L, Zannino, D, Williamson, E, Davis, TME, Laakso, M, Kesäniemi, YA, Zhang, J, Sy, RW, et al.
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
European Heart Journal
31(1)
:
92 -99
2010
view publication
-
Taskinen, M-R, Sullivan, DR, Ehnholm, C, Whiting, M, Zannino, D, Simes, RJ, Keech, AC, Barter, PJ.
Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate.
Arteriosclerosis Thrombosis and Vascular Biology
29(6)
:
950 -955
2009
view publication